Enveloped Virus Inactivation by Fatty Acid Derivatives
Open Access
- 1 January 1979
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 15 (1) , 134-136
- https://doi.org/10.1128/aac.15.1.134
Abstract
The enveloped bacteriophage φ6 has been shown to be a valuable model system for the preliminary screening of compounds that might be expected to inactivate herpes simplex virus and other enveloped mammalian viruses. A variety of fatty acid derivatives that form fluid micelles in aqueous media have been found to be potent inactivators of φ6. The chemical nature of the polar head group, the length of the alkyl chain(s), and the extent and geometry of unsaturation are all important parameters in determining the antiviral effectiveness of this class of compounds.This publication has 7 references indexed in Scilit:
- Extreme Sensitivity of Enveloped Viruses, Including Herpes Simplex, to Long-Chain Unsaturated Monoglycerides and AlcoholsAntimicrobial Agents and Chemotherapy, 1979
- Antiviral Effects of Amphotericin B Methyl EsterAntimicrobial Agents and Chemotherapy, 1978
- Inactivation and Inhibition of Replication of the Enveloped Bacteriophage φ6 by Fatty AcidsAntimicrobial Agents and Chemotherapy, 1977
- Inactivation of Lipid-Containing Viruses by Long-Chain AlcoholsAntimicrobial Agents and Chemotherapy, 1977
- Ultrastructure and Life Cycle of the Lipid-containing Bacteriophage 6Journal of General Virology, 1976
- Butylated Hydroxytoluene Inactivated Lipid-Containing VirusesScience, 1975
- Bacteriophage phi6: a Lipid-Containing Virus of Pseudomonas phaseolicola.1973